Evidence map›Paper›PMID 35733892›Full record

ArticleChemical science2022

César Leroy, Sébastien Mittelette, Gautier Félix, Nicolas Fabregue, Jessica Špačková, Philippe Gaveau, Thomas-Xavier Métro, Danielle Laurencin

Abstract read
In one paragraph

Article in Chemical science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

César LeroyICGM, Univ Montpellier, CNRS, ENSCM Montpellier France cesar.leroy@umontpellier.fr danielle.laurencin@umontpellier.fr.ORCID https://orcid.org/0000-0002-9013-5552
Sébastien MitteletteICGM, Univ Montpellier, CNRS, ENSCM Montpellier France cesar.leroy@umontpellier.fr danielle.laurencin@umontpellier.fr.ORCID https://orcid.org/0000-0003-2471-1088
Gautier FélixICGM, Univ Montpellier, CNRS, ENSCM Montpellier France cesar.leroy@umontpellier.fr danielle.laurencin@umontpellier.fr.ORCID https://orcid.org/0000-0002-2761-6353
Nicolas FabregueICGM, Univ Montpellier, CNRS, ENSCM Montpellier France cesar.leroy@umontpellier.fr danielle.laurencin@umontpellier.fr.ORCID https://orcid.org/0000-0002-2574-2364
Jessica ŠpačkováICGM, Univ Montpellier, CNRS, ENSCM Montpellier France cesar.leroy@umontpellier.fr danielle.laurencin@umontpellier.fr.ORCID https://orcid.org/0000-0001-6255-8788
Philippe GaveauICGM, Univ Montpellier, CNRS, ENSCM Montpellier France cesar.leroy@umontpellier.fr danielle.laurencin@umontpellier.fr.
Thomas-Xavier MétroIBMM, Univ Montpellier, CNRS, ENSCM Montpellier France.ORCID https://orcid.org/0000-0003-2280-3595
Danielle LaurencinICGM, Univ Montpellier, CNRS, ENSCM Montpellier France cesar.leroy@umontpellier.fr danielle.laurencin@umontpellier.fr.ORCID https://orcid.org/0000-0002-7445-0528

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We present a new

Identifiers

PMID35733892
PMCPMC9159074

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.